JP2024530926A - 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 - Google Patents

低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 Download PDF

Info

Publication number
JP2024530926A
JP2024530926A JP2024506789A JP2024506789A JP2024530926A JP 2024530926 A JP2024530926 A JP 2024530926A JP 2024506789 A JP2024506789 A JP 2024506789A JP 2024506789 A JP2024506789 A JP 2024506789A JP 2024530926 A JP2024530926 A JP 2024530926A
Authority
JP
Japan
Prior art keywords
seq
recombinant
arahl
mutant polypeptide
ara
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530926A5 (cg-RX-API-DMAC7.html
Inventor
オフラン、ヤナイ
デイビッド、モシェ ベン
ガーバー、オーリー マーク
キロス、シー ナフタリー
ディアマント、ギル
コーヘン、アルモグ ブレグマン
コーマン、マアヤン
チュプリン、アンナ
ソレク、ゾハル ビロン
シュラムコビッチ、リオール ローゼンフェルド
ロテム、エタイ
ガット、ヤイール
Original Assignee
ウッコ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウッコ インコーポレイテッド filed Critical ウッコ インコーポレイテッド
Publication of JP2024530926A publication Critical patent/JP2024530926A/ja
Publication of JP2024530926A5 publication Critical patent/JP2024530926A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024506789A 2021-08-03 2022-08-02 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 Pending JP2024530926A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US202163228604P 2021-08-03 2021-08-03
US202163228606P 2021-08-03 2021-08-03
US63/228,606 2021-08-03
US63/228,604 2021-08-03
US202163284108P 2021-11-30 2021-11-30
US63/284,108 2021-11-30
US202163292441P 2021-12-22 2021-12-22
US63/292,441 2021-12-22
US202263311117P 2022-02-17 2022-02-17
US63/311,117 2022-02-17
US202263319393P 2022-03-14 2022-03-14
US202263319394P 2022-03-14 2022-03-14
US63/319,393 2022-03-14
US63/319,394 2022-03-14
PCT/IB2022/057144 WO2023012652A2 (en) 2021-08-03 2022-08-02 Hypoallergenic peanut allergens, production and use thereof

Publications (2)

Publication Number Publication Date
JP2024530926A true JP2024530926A (ja) 2024-08-27
JP2024530926A5 JP2024530926A5 (cg-RX-API-DMAC7.html) 2025-07-28

Family

ID=85155450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506789A Pending JP2024530926A (ja) 2021-08-03 2022-08-02 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用

Country Status (6)

Country Link
US (2) US20240390485A1 (cg-RX-API-DMAC7.html)
EP (1) EP4380957A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024530926A (cg-RX-API-DMAC7.html)
AU (1) AU2022323847A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226900A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023012652A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024224738A1 (en) * 2023-02-23 2025-09-18 The General Hospital Corporation, D/B/A Massachusetts General Hospital Mutant ara h 2 and ara h 6 proteins and uses thereof
JP2026525506A (ja) 2023-06-12 2026-07-31 デセントゥム オーワイ 主要なピーナッツアレルゲンであるAra h 2の低アレルゲン性バリアント
WO2026080920A1 (en) 2024-10-13 2026-04-16 Ukko Inc. Mrna vaccine for peanut allergy treatment

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11507840A (ja) * 1995-12-29 1999-07-13 ユニバーシティ オブ アーカンソー ピーナッツアレルゲンおよび方法
JP2002501748A (ja) * 1998-01-31 2002-01-22 ユニバーシティ オブ アーカンソー アレルギー反応を減少させるための方法および試薬
WO2002074250A2 (en) * 2001-03-16 2002-09-26 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US20080075725A1 (en) * 2004-06-10 2008-03-27 Monash University Novel Immunointeractive Molecules and uses Thereof
WO2013171268A1 (en) * 2012-05-15 2013-11-21 Biomay Ag Allergen variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3563159A1 (en) * 2016-12-29 2019-11-06 Ukko Inc. Methods for identifying and de-epitoping allergenic polypeptides
JP2021523185A (ja) * 2018-05-15 2021-09-02 イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. アレルゲンを含む改善されたlamp構築物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11507840A (ja) * 1995-12-29 1999-07-13 ユニバーシティ オブ アーカンソー ピーナッツアレルゲンおよび方法
JP2002501748A (ja) * 1998-01-31 2002-01-22 ユニバーシティ オブ アーカンソー アレルギー反応を減少させるための方法および試薬
WO2002074250A2 (en) * 2001-03-16 2002-09-26 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US20080075725A1 (en) * 2004-06-10 2008-03-27 Monash University Novel Immunointeractive Molecules and uses Thereof
WO2013171268A1 (en) * 2012-05-15 2013-11-21 Biomay Ag Allergen variants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STAUDIGL, BARBARA JADWIGA, "PRODUCTION AND CHARACTERIZATION OF A HYPOALLERGENIC VARIANT OF THE MAJOR PEANUT ALLERGEN ARA H 2 IN, JPN6026017937, 2016, pages 11 - 28, ISSN: 0005856588 *

Also Published As

Publication number Publication date
EP4380957A4 (en) 2025-09-03
WO2023012652A3 (en) 2023-04-06
WO2023012652A2 (en) 2023-02-09
EP4380957A2 (en) 2024-06-12
US20240117020A1 (en) 2024-04-11
US20240390485A1 (en) 2024-11-28
CA3226900A1 (en) 2023-02-09
AU2022323847A1 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
EP2882453B1 (en) Anti-dengue virus antibodies and uses thereof
US20240117020A1 (en) Hypoallergenic peanut allergens, production and use thereof
AU2015217149B2 (en) Novel full spectrum anti-dengue antibody
Asturias et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
Yermakova et al. Sub-domains of ricin’s B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies
TR201812060T4 (tr) Hipoalerjen.
US9040054B2 (en) Hypoallergenic molecules
Shafaghi et al. A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
Kosztyu et al. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice
Levin et al. Phl p 1–specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment
Nilsson et al. In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity
CN117979981A (zh) 低过敏原性的花生过敏原、其产生及其用途
JP2025538106A (ja) ピーナッツに対する脱感作を誘導するための組成物及び方法
CN119039430B (zh) 靶向结核分枝杆菌MctB的保护性单克隆抗体及制备方法和应用
CN118930645B (zh) 靶向结核分枝杆菌OmpA的保护性单克隆抗体及制备方法和应用
US20250206812A1 (en) Single domain antibodies against bee venom epitopes
US20240400692A1 (en) Celiac disease epitopes
WO2013104901A2 (en) Novel therapies
EP2281836B1 (en) Hybrid proteins from Parietaria judaica major allergens and uses thereof
CN110938150A (zh) E型肉毒毒素重组hn-l抗原的制备方法及其应用
Nilsson et al. In Vitro Evolution of Allergy Vaccine Candidates, with Maintained
CN121311496A (zh) 主要花生变应原Ara h 2的低变应原变体
HK1210054B (en) Anti-dengue virus antibodies and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250717

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250717

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260810